Vaccine for COVID-19 safe, effective in first human clinical trial, study says
A potential vaccine for COVID-19 appears to be safe and able to generate an immune response against the virus, according to a study published Friday by The Lancet.
Authors: Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, Abbott W, Mears E, Steele R, McKee J, Muscroft-Taylor A, Ameratunga S, Medlicott N, Das S, Rolleston W, Quiñones-Mateu M, Petousis-Harris H, Jordan A Abstract COVID-19 is a new zoonotic disease caused by the SARS-CoV-2 virus. Since its emergence in Wuhan City, China, the virus has rapidly spread across the globe causing calamitous health, economic and societal consequences. It causes disproportionately severe disease in the elderly and those with co-morbidities, such as hypertension and diabetes. There is currently no proven treatment ...
Federal officials issued warning letters to two groups this week, accusing them of selling fraudulent and unapproved products related to Covid-19.
China's first coronavirus vaccine trial leaves some experts skeptical.
A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
Immunizations are falling because of pandemic disruptions, raising fears of surges in preventable disease. Lockdowns complicate the Muslim holiday Eid. China ’s National People’s Congress offers a show of strength.
The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020.Reuters Health Information
Advances in viral detection in bovine respiratory disease (BRD) have resulted from advances in viral sequencing of respiratory tract samples. New viruses detected include influenza D virus, bovine coronavirus, bovine rhinitis A, bovine rhinitis B virus, and others. Serosurveys demonstrate widespread presence of some of these viruses in North American cattle. These viruses sometimes cause disease after animal challenge, and some have been found in BRD cases more frequently than in healthy cattle. Continued work is needed to develop reagents for identification of new viruses, to confirm their pathogenicity, and to determine ...
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.
There's encouraging news from the two leading experimental coronavirus vaccine trials. Researchers in both trials have reported the presence of antibodies in volunteers after injecting them with experimental vaccines. Charlie D'Agata reports in the series "Racing to a Cure."